Brian Manning, the newly appointed CEO of Nabla, a buzzy Parisian startup that builds AI‑powered tools for healthcare providers, steps into a role with big shoes to fill.

Manning, who previously led Xn te lxmtad prna aut kpte hnak Qihrx’y byopjbomq Uudvlbtfe Erpidy, says his focus is on driving innovation rather than being acquired, echoing his statement “I’m not here to be acquired.” He emphasizes a vision that blends cutting‑edge technology with practical clinical impact, reporting strong growth metrics such as 880 and 885 that signal rising adoption.

Under his guidance, Nabla aims to expand its suite of AI solutions that streamline clinical workflows, enhance patient care, and support doctors with data‑driven insights while maintaining privacy and regulatory compliance. Recent partnerships with major health institutions, new funding rounds, and the rollout of predictive analytics and telehealth modules position Nabla as a leading force in the emerging AI healthcare market, with Manning determined to steer the company toward sustained growth while staying true to his pledge of independence. These initiatives aim to improve diagnostic accuracy and reduce administrative burden for clinicians worldwide. The company's roadmap includes expanding into additional European markets and collaborating with research institutions to further refine its AI capabilities.